Investor Alert

New York Markets Open in:

Syros Pharmaceuticals Inc.



After Hours

 --Quotes are delayed by 20 min

Sep 21, 2023, 6:04 p.m.





-0.18 -4.56%


Volume 330

Quotes are delayed by 20 min


Previous close

$ 3.92

$ 3.95


+0.03 +0.77%

Day low

Day high




52 week low

52 week high




Annual Financials for Syros Pharmaceuticals Inc.

Fiscal year is January-December. All values USD millions. 20182019202020212022 5-year trend
Sales/Revenue 2.05M1.98M15.09M23.49M14.88M
Cost of Goods Sold (COGS) incl. D&A ----2.97M
COGS excluding D&A -----
Depreciation & Amortization Expense 1.6M2.72M3.04M3.02M2.97M
Depreciation 1.6M2.72M3.04M3.02M2.97M
Amortization of Intangibles -----
Gross Income ----11.91M
20182019202020212022 5-year trend
SG&A Expense 64.74M77M94.36M119.89M138.28M
Research & Development 50.18M58.25M76.07M97.11M109.24M
Other SG&A 14.56M18.76M18.29M22.78M29.04M
Other Operating Expense -----
Unusual Expense --375,000(16.68M)(33.71M)
EBIT after Unusual Expense --(82.67M)(82.74M)(92.65M)
Non Operating Income/Expense 2.02M2.3M---
Non-Operating Interest Income --426,00087,0002.13M
Equity in Affiliates (Pretax) -----
Interest Expense --1.79M3.91M4.13M
Gross Interest Expense --1.79M3.91M4.13M
Interest Capitalized -----
Pretax Income (62.28M)(75.44M)(84.04M)(86.56M)(94.65M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (62.28M)(75.44M)(84.04M)(86.56M)(94.65M)
Minority Interest Expense -----
Net Income (62.28M)(75.44M)(84.04M)(86.56M)(94.65M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (62.28M)(75.44M)(84.04M)(86.56M)(94.65M)
Preferred Dividends -----
Net Income Available to Common (62.28M)(75.44M)(84.04M)(86.56M)(94.65M)
EPS (Basic) (19.07)(18.76)(18.25)(13.84)(7.49)
Basic Shares Outstanding 3.27M4.02M4.61M6.25M12.63M
EPS (Diluted) (19.07)(18.76)(18.25)(13.84)(7.49)
Diluted Shares Outstanding 3.27M4.02M4.61M6.25M12.63M
EBITDA (62.69M)(75.02M)(79.26M)(96.4M)(123.4M)
Link to MarketWatch's Slice.